How can a drug that suppresses testosterone also be used to restore it?

Triptorelin's paradox is in its dose and duration. GnRH receptor activation is stimulatory — it triggers LH and FSH release. But sustained, continuous GnRH receptor exposure causes receptor downregulation and desensitization, which kills LH/FSH output and suppresses testosterone. Depot formulations maintain continuous receptor exposure to ensure suppression (for prostate cancer). A single low-dose aqueous injection produces brief stimulatory receptor activation that generates a powerful LH/FSH surge — then the peptide clears before receptor desensitization occurs. The key is brief activation, not sustained exposure.

What is the PCT dose and timing for triptorelin?

The biohacker/bodybuilding community has empirically converged on 50–100 mcg (aqueous solution, not depot) as a single subcutaneous injection for PCT. 100 mcg is most commonly reported as effective. Timing: approximately 2 weeks after the last injection of long-acting testosterone esters (enanthate, cypionate) to allow the steroid to clear enough that HPG axis recovery can begin. One injection only — repeating risks triggering desensitization and suppression instead of stimulation. Many users follow with 4 weeks of SERM (clomid or nolvadex) for continued pituitary support.

How does triptorelin PCT compare to SERM-based PCT?

SERM (clomid, nolvadex) PCT works by blocking estrogen negative feedback at the pituitary, gradually stimulating LH recovery over 4-6 weeks. Triptorelin PCT works by directly stimulating GnRH receptors for an acute LH surge, jumpstarting testicular function more rapidly. Triptorelin advantage: faster recovery, single injection vs. weeks of daily SERMs. Triptorelin risk: dose error (too high or repeated) causes suppression rather than stimulation. Many experienced users combine both: triptorelin for the initial LH surge, then 4 weeks of SERMs for sustained pituitary support.

What bloodwork is needed to monitor triptorelin PCT?

LH, FSH, and total testosterone at 2 and 4 weeks post-injection. LH should be elevated at 48 hours post-injection if the stimulatory phase worked (rapid testing is rarely practical but useful if accessible). Testosterone should be rising by week 2. If testosterone is not recovering by week 4, add SERM protocol or consult an endocrinologist — the triptorelin injection may have triggered desensitization rather than stimulation. Ongoing monitoring of libido, energy, mood, and testicular size alongside bloodwork gives a comprehensive recovery picture.

COMPOUND LIBRARY·TRIPTORELIN

COMPOUND PROFILE · PEPPERLEDGER

Triptorelin (Trelstar · Decapeptyl)

Type

Synthetic GnRH analog — decapeptide with D-Trp⁶ substitution for increased potency and resistance to enzymatic degradation

Class

GnRH receptor agonist — paradoxical: initial stimulation then prolonged HPG suppression at continuous doses; acute stimulation at single low dose

Administration

IM or SC depot injection (approved use) · Single low-dose SC aqueous injection (PCT use)

Half-life

Short peptide half-life; depot formulations extend to months. Single aqueous injection: hours.

Most studied use

Prostate cancer (approved) · Central precocious puberty (approved) · HPG axis restoration post-cycle (off-label PCT)

Regulatory status

FDA-APPROVED (Trelstar) — prostate cancer androgen deprivation and central precocious puberty · PCT use is off-label with no controlled trial evidence

Human evidence

Strong for approved indications · PCT application is community-derived, mechanistically sound, no RCT evidence

Preclinical evidence

Well-characterized GnRH receptor pharmacology across decades of research

EDUCATIONAL TOOL — NOT MEDICAL ADVICE

What is triptorelin?

Triptorelin is a synthetic GnRH analog with a critical pharmacological property: at continuous or depot doses, it initially stimulates then desensitizes GnRH receptors, suppressing LH, FSH, and testosterone/estrogen to castrate levels. This is why it's approved for prostate cancer (medical castration) and precocious puberty (halting early puberty). The paradox that biohacker communities exploit: at a single low dose, the initial stimulatory phase — before desensitization sets in — can produce a powerful LH and FSH surge that stimulates the testes to restart natural testosterone production.

The context is anabolic steroid post-cycle therapy (PCT). After a steroid cycle, exogenous testosterone suppresses the HPG axis — LH and FSH fall to near zero, the testes atrophy, and natural testosterone production stops. Recovery can take months without intervention. The standard PCT approach uses SERMs (clomid, nolvadex) to gradually stimulate LH recovery. Triptorelin's single-injection approach is different: one low dose produces an acute LH/FSH surge that jumpstarts testicular function rapidly — but requires precise timing and dose to avoid triggering the desensitization that causes suppression rather than stimulation.

This PCT application is entirely off-label and community-derived — no controlled trials. The theoretical basis is mechanistically sound. The biohacker community has empirically converged on very low doses (50–100 mcg single injection). Getting the dose wrong can produce further HPG suppression rather than stimulation — this is the primary risk and requires careful dose management and monitoring.

How it works

GnRH Receptor — Stimulation vs. Suppression Paradox

Triptorelin binds GnRH receptors on anterior pituitary gonadotrophs. Initial binding activates the receptor, triggering LH and FSH surge (stimulatory phase). Continuous or repeated binding causes receptor downregulation and desensitization — LH and FSH fall, sex hormone production ceases (suppressive phase). Depot formulations maintain continuous exposure, ensuring sustained desensitization. Single low-dose aqueous injection: stimulatory phase occurs, then the peptide clears before desensitization sets in. The pharmacological difference between a cancer treatment and a PCT tool is entirely in dose and duration.

PCT Mechanism — The Single-Injection Approach

A single low-dose aqueous triptorelin injection produces an acute GnRH receptor activation that generates a robust LH and FSH surge — more potent than gonadorelin's short pulses or clomid's estrogen blockade. This LH surge stimulates Leydig cells in the testes, initiating testosterone production. The key: the peptide must clear before sustained receptor exposure causes desensitization. At 50–100 mcg single SC injection, the stimulatory effect dominates. LH peaks within hours, testosterone rises within days.

Comparison to Gonadorelin and Kisspeptin

Gonadorelin (short half-life) given pulsatilely: maintains ongoing LH/FSH stimulation but requires frequent injections. Kisspeptin stimulates GnRH neurons upstream — more physiological, axis-preserving. Triptorelin single low-dose: acute powerful LH surge, then cleared — one-shot HPG axis restart. Triptorelin's single-injection approach is most practical for post-cycle HPG restart; gonadorelin is better for ongoing TRT co-administration; kisspeptin for upstream HPG optimization without TRT.

What the research shows

HUMAN EVIDENCE — APPROVED INDICATIONS

STUDYUrology · 2006

Triptorelin for prostate cancer — androgen deprivation

Crawford ED et al.

Phase III. Triptorelin depot produces castrate testosterone levels within 4 weeks. Establishes the suppressive mechanism in humans. Clinical basis for FDA-approved androgen deprivation therapy indication.

View on PubMed →

PCT MECHANISM — FOUNDATIONAL SCIENCE

STUDYScience · 1978

Pulsatile vs. continuous GnRH: stimulation vs. suppression

Belchetz PE et al.

Foundational paper establishing that pulsatile GnRH stimulates LH/FSH while continuous GnRH causes suppression via receptor desensitization. The mechanistic basis for understanding why single-dose triptorelin stimulates rather than suppresses.

View on PubMed →

WHAT THE RESEARCH SHOWS

✓KNOWN

✓GnRH receptor stimulation → suppression pharmacology well-characterized over decades
✓Single brief GnRH activation produces LH surge before desensitization — mechanistically established
✓Depot triptorelin safely achieves medical castration in approved indications
✓PCT single-injection approach mechanistically sound

?UNCERTAIN

?Optimal PCT dose (50 vs. 100 mcg) — no controlled comparison
?Ideal timing relative to last steroid dose across different steroid half-lives
?Controlled comparison vs. SERM-based PCT for HPG recovery speed and completeness

What the community reports

—Rapid testosterone recovery — LH and FSH surge within 24–48 hours; testosterone rising within a week vs. 4–8 weeks for SERM-only PCT

—Testicular reactivation — testicles returning to normal size faster than with conventional PCT

—Dose sensitivity: community settled on 50–100 mcg as the sweet spot — below produces insufficient LH surge, above risks triggering desensitization

—Timing matters critically: must be timed correctly based on the steroid's half-life — long esters need ~2 weeks to clear

—One-and-done approach: many prefer the simplicity of one injection vs. weeks of daily SERM dosing

—Risk of getting it wrong: users who dose too high or repeat the injection can trigger suppression rather than recovery — the primary community-acknowledged risk

Common misconceptions

"Triptorelin for PCT is the same as triptorelin for prostate cancer."

REALITY

Opposite effects from different dosing strategies. Prostate cancer treatment uses depot formulations producing months of continuous GnRH receptor activation — causing complete HPG suppression and castrate testosterone. PCT use is a single low-dose aqueous injection producing brief stimulation then clearance before desensitization. Same compound, pharmacologically opposite outcome based entirely on dose and duration.

"More triptorelin means faster PCT recovery."

REALITY

Higher doses or repeated injections produce receptor desensitization — the opposite of the desired PCT effect. The dose must be low enough that the peptide clears before sustained receptor exposure causes downregulation. Getting greedy with the dose is the most common PCT mistake with triptorelin.

"Triptorelin PCT has clinical evidence."

REALITY

Zero controlled PCT trials. The PCT application is entirely community-derived based on mechanistic extrapolation from the approved indications. The mechanism is sound; the evidence is empirical community knowledge and basic GnRH pharmacology science, not clinical PCT data.

HPG AXIS TOOLS — COMPARISON

Triptorelin: single-injection PCT restart — acute LH surge, one and done. Gonadorelin: pulsatile ongoing LH stimulation — best for TRT co-administration to preserve testicular function. Kisspeptin: upstream HPG stimulation via GnRH neurons — most physiological, axis-preserving.

RECONSTITUTION CALCULATOR

Peptide in vial (mg)BAC water (mL)Desired dose (mcg)

EDUCATIONAL TOOL — NOT MEDICAL ADVICE · VERIFY WITH YOUR CLINICIAN

AI COACH PREVIEW

I just finished a 12-week testosterone cycle. How do I time a triptorelin PCT shot correctly?

Timing is the most important variable with triptorelin PCT — get it wrong and you suppress instead of stimulate. Let me walk through the calculation. The principle: you want the triptorelin injection when exogenous testosterone has cleared enough that your body is ready to resume natural production, but before your HPG axis has been suppressed so long that it's unresponsive. Timing by ester: For testosterone enanthate or cypionate (most common — half-life ~5-7 days): Wait 10-14 days after your last injection before the triptorelin shot. This gives the exogenous testosterone time to clear, while not waiting so long that HPG recovery becomes more difficult. For testosterone propionate (half-life ~2 days): Wait 3-5 days after last injection. For testosterone undecanoate (half-life ~20 days): Wait 3 weeks. Dose: 100 mcg single SC injection — community consensus as most effective. Inject once only. Do not repeat. After the triptorelin: wait 5-7 days, then begin SERM (clomid 50 mg/day or nolvadex 20 mg/day) for 4 weeks. The triptorelin gives the initial LH surge to jumpstart testicular function; the SERM sustains pituitary stimulation while the testes fully reactivate. Bloodwork: LH, FSH, and total testosterone at week 2 and week 4 post-triptorelin. Testosterone should be rising by week 2. If it's not moving by week 4, you may have triggered desensitization rather than stimulation — consult an endocrinologist. What ester did you run and what was your last injection date?

CONTINUE IN THE APP

Open PepperLedger to track your triptorelin protocol →

Free to join. No credit card. Ask the Coach about your PCT timing and bloodwork monitoring once you're in.

Free to join · No credit card · 23-day Pro trial included